Skip to main content

Advertisement

Log in

Fertility Management for the Hemato-Oncologist

  • Review Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

For cancer survivors, social parenthood buffers distress and improves quality of life. It is important that physicians dealing with treatment of malignancies are aware of this patient perspective. This review deals with risks of infertility with hematological malignancies and chemotherapy, modes of fertility preservation interventions, time and barriers to referral to specialists offering these interventions. This review aims to guide the hemato-oncologist to make an informed decision with the patient and the partner about fertility preservation at the right time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Canada AL, Schover LR (2012) The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 21(2):134–143

    Article  PubMed  Google Scholar 

  2. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917–2931

    Article  PubMed  Google Scholar 

  3. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500–2510

    Article  PubMed  PubMed Central  Google Scholar 

  4. Quinn GP, Vadaparampil ST, Bell-Ellison BA, Gwede CK, Albrecht TL (2008) Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Soc Sci Med 66(3):784–789

    Article  PubMed  Google Scholar 

  5. Brougham MF, Wallace WH (2005) Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 131(2):143–155

    PubMed  Google Scholar 

  6. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF et al (1992) Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166(3):788–793

    Article  CAS  PubMed  Google Scholar 

  7. Chatterjee R, Kottaridis PD (2002) Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplant 30(10):629–635

    Article  CAS  PubMed  Google Scholar 

  8. Chemes HE (2001) Infancy is not a quiescent period of testicular development. Int J Androl 24(1):2–7

    Article  CAS  PubMed  Google Scholar 

  9. Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH (2002) Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 360(9330):361–367

    Article  CAS  PubMed  Google Scholar 

  10. Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA et al (2014) Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 15(11):1215–1223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Agarwal A, Shekarriz M, Sidhu RK, Thomas AJ Jr (1996) Value of clinical diagnosis in predicting the quality of cryopreserved sperm from cancer patients. J Urol 155(3):934–938

    Article  CAS  PubMed  Google Scholar 

  12. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O et al (2001) Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol 12(9):1307–1311

    Article  CAS  PubMed  Google Scholar 

  13. Hallak J, Mahran A, Chae J, Agarwal A (2000) The effects of cryopreservation on semen from men with sarcoma or carcinoma. J Assist Reprod Genet 17(4):218–221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Trottmann M, Becker AJ, Stadler T, Straub J, Soljanik I, Schlenker B et al (2007) Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol 52(2):355–367

    Article  PubMed  Google Scholar 

  15. Pal L, Leykin L, Schifren JL, Isaacson KB, Chang YC, Nikruil N et al (1998) Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod 13(7):1837–1840

    Article  CAS  PubMed  Google Scholar 

  16. Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT (2008) Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers. Nat Clin Pract Oncol 5(2):78–89

    Article  PubMed  Google Scholar 

  17. Chatterjee R, Haines GA, Perera DM, Goldstone A, Morris ID (2000) Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod 15(4):762–766

    Article  CAS  PubMed  Google Scholar 

  18. Leader A, Lishner M, Michaeli J, Revel A (2011) Fertility considerations and preservation in haemato-oncology patients undergoing treatment. Br J Haematol 153(3):291–308

    Article  PubMed  Google Scholar 

  19. Loren AW (2015) Fertility issues in patients with hematologic malignancies. Hematol Am Soc Hematol Educ Program 2015:138–145

    Google Scholar 

  20. Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM et al (1987) The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 67(4):419–426

    Article  CAS  PubMed  Google Scholar 

  21. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 31(3):363–373

    Article  CAS  Google Scholar 

  22. Meistrich ML (2009) Male gonadal toxicity. Pediatr Blood Cancer 53(2):261–266

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18(1):117–121

    Article  CAS  PubMed  Google Scholar 

  24. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358(9278):271–276

    Article  CAS  PubMed  Google Scholar 

  25. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7):3045–3052

    CAS  PubMed  Google Scholar 

  26. Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS et al (2006) Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 37(11):1023–1029

    Article  CAS  PubMed  Google Scholar 

  27. Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S et al (2011) Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 17(2):157–166

    Article  PubMed  Google Scholar 

  28. Mahajan N (2015) Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci 8(1):3–13

    Article  PubMed  PubMed Central  Google Scholar 

  29. Medicine PCoASfR (2013) Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 100(5):1214–1223

    Article  Google Scholar 

  30. National Institute for Health and Clinical Excellence (2013) Fertility: assessment and treatment for people with fertility problems (update). (Clinical guideline 156). www.nice.org.uk/CG156

  31. Revel A, Revel-Vilk S (2008) Pediatric fertility preservation: is it time to offer testicular tissue cryopreservation? Mol Cell Endocrinol 282(1–2):143–149

    Article  CAS  PubMed  Google Scholar 

  32. Alvarez RM, Ramanathan P (2016) Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Hum Reprod. doi:10.1093/humrep/dew158

    PubMed  Google Scholar 

  33. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H et al (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23(5):1007–1013

    Article  PubMed  Google Scholar 

  34. Meistrich ML, Shetty G (2008) Hormonal suppression for fertility preservation in males and females. Reproduction 136(6):691–701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Chen H, Li J, Cui T, Hu L (2011) Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev (11):CD008018. doi:10.1002/14651858.CD008018.pub2

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepesh Lad.

Ethics declarations

Conflicts of interest

The authors have no potential conflicts of interest to disclose.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karunakaran, P., Malhotra, P. & Lad, D. Fertility Management for the Hemato-Oncologist. Indian J Hematol Blood Transfus 34, 13–18 (2018). https://doi.org/10.1007/s12288-017-0887-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-017-0887-8

Keywords

Navigation